Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Marlana, Orloff"'
Autor:
Sapna Patel, Alain Mita, Kyriakos P Papadopoulos, Justine Cohen, Alexander Shoushtari, Jordi Rodon, Marlana Orloff, Marya Chaney, Carolyn Muller, Jessica Lin, Tina Garyantes, Monica Mita, Christopher Natale, Jeffrey Ishizuka
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/eea4b5f77786436a94e0b9b2b34ee5b4
Autor:
Brendan Curti, Koustubh Ranade, Laura Collins, Marlana Orloff, Emma Leach, Sarah Stanhope, Adel Benlahrech, Kevin Kim
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/631b1a31539341579031893888fc8433
Autor:
David Geller, Ashley Moody, Richard Carvajal, Cara Haymaker, Sunil Reddy, Jose Lutzky, Shailender Bhatia, Diwakar Davar, Bartosz Chmielowski, Theresa Medina, Eric Wehrenberg-Klee, Marlana Orloff, Rahul Sheth, Sapna P Patel, Robert Knight, Jason Laporte, Prajna Guha, Bryan Cox, Steven Katz, Paula Novelli, Joshua D Kuban, Ann-Marie Hulstine, Kamaneh Montazeri, Shaheer A Khan, Lindsay Thornton, Anthony Lucci, Vanessa Sarli, Salyna Meas, Chandra C Ghosh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/4699634df0af46c0a34fa5697092f712
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Oncolytic viral immunotherapies are agents which can directly kill tumor cells and activate an immune response. Oncolytic viruses (OVs) range from native/unmodified viruses to genetically modified, attenuated viruses with the capacity to preferential
Externí odkaz:
https://doaj.org/article/3fbaea3c48044574ac3629c9261ae9c2
Autor:
Jessica C Hassel, Mark R Middleton, Alexander N Shoushtari, Omid Hamid, Paolo A Ascierto, Todd M Bauer, John M Kirkwood, Friedegund Meier, Marlana Orloff, Paul C Lorigan, Chris Holland, Cornelia Mauch, Ramakrishna Edukulla, April K S Salama, Thomas R Jeffry Evans, Shaad E Abedin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background Immune checkpoint inhibitors have significantly improved outcomes in first line cutaneous melanoma. However, there is a high unmet need for patients who progress on these therapies and combination therapies are being explored to improve ou
Externí odkaz:
https://doaj.org/article/29e4906b8b284394a0be7d5dc9bc48bf
Autor:
Jessica C Hassel, James Larkin, Madan Jagasia, Harriet Kluger, Omid Hamid, Jeffrey Weber, Jason Chesney, Amod Sarnaik, John M Kirkwood, Eric Whitman, Martin Wermke, Evidio Domingo-Musibay, Theresa Medina, Sajeve Thomas, Wen Shi, Karl D Lewis, Nikhil I Khushalani, Parameswaran Hari, Marlana Orloff, Mike Cusnir, Giao Q Phan, Andrew J S Furness, Michael E Egger, Friedrich Graf Finckenstein, Giri Sulur
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 12 (2022)
Background Patients with advanced melanoma have limited treatment options after progression on immune checkpoint inhibitors (ICI). Lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, demonstrated an investigator-assess
Externí odkaz:
https://doaj.org/article/900e2415861b4b7ead600bdf8b2b9e19
Autor:
Alexander Z. Wei, Matan Uriel, Agata Porcu, Michael P. Manos, Ann C. Mercurio, Michael M. Caplan, Liam Hulse, Rino S. Seedor, Marta Holovatska, Jasmine Francis, Shaheer A. Khan, Diana E. McDonnell, Dmitry Bogomolny, Takami Sato, Brian P. Marr, Rizwan Haq, Marlana Orloff, Alexander Shoushtari, Richard D. Carvajal
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Metastatic uveal melanoma (mUM) is an advanced ocular malignancy characterized by a hepatotropic pattern of spread. As the incidence of brain metastases (BM) in mUM patients has been thought to be low, routine CNS surveillance has not been recommende
Externí odkaz:
https://doaj.org/article/bec726a3073a437abfa5b4f685292205
Autor:
Mark Middleton, Omid Hamid, Todd Bauer, Jessica Hassel, Friedegund Meier, Paolo Ascierto, John Kirkwood, Alexander Shoushtari, Marlana Orloff, April Salama, Paul Lorigan, Jeff Evans, Chris Holland, Shaad Abdullah, Cornelia Mauch, Ramakrishna Edukulla, Renee Mundy
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/3a4461a2d25c43febc0bcaa2b6a0e695
Autor:
Hui Zhou, Ying Liu, Fang Liu, Siqing Fu, Nehal Lakhani, Marlana Orloff, Kedan Lin, Shuling Yan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/355c38bd9a934df48096a0b0cf191e3a
Publikováno v:
Cancers, Vol 13, Iss 21, p 5503 (2021)
Despite successful treatment of primary uveal melanoma, up to 50% of patients will develop systemic metastasis. Metastatic disease portends a poor outcome, and no adjuvant or metastatic therapy has been FDA approved. The genetic landscape of uveal me
Externí odkaz:
https://doaj.org/article/8101a6b7c1cd4916b4648fdac49fccaa